Aclaris Q2 FY26 net loss widens to $21.5 million; revenue slips to $1.6 million - ACRS News | RalliesAclaris Q2 FY26 net loss widens to $21.5 million; revenue slips to $1.6 million
A
ACRS• Quarterly results and expenses
- Aclaris posted a GAAP net loss of $21.5 million, widening from $15.4 million a year earlier; loss per share widened to $0.15 from $0.13.
- Revenue slipped to $1.63 million from $1.78 million; R&D expenses climbed to $18.07 million from $11.45 million.
- Cash, cash equivalents and marketable securities rose to $170.62 million at June 30 from $151.36 million at Dec. 31.
Financing and program timelines
- Subsequent to quarter-end, it sold 7,300,000 shares via its ATM for gross proceeds of $40.2 million.
- Management reaffirmed 2H 2026 top-line timelines for ATI-052 Phase 1b POC trials; bosakitug Phase 2 AD readout remains targeted for Q4 2026.
